1h Free Analyst Time
About Biologics
Speak directly to the analyst to clarify any post sales queries you may have.
Biologics, biopharmaceutical, biologic drugs, or biological drugs refer to drugs that are extracted, synthesized, and manufactured from biological material derived from living sources, such as humans, plants, and animals. Biologics manufacturing refers to the production of such drugs.
The analysts forecast the Global Biologics Manufacturing Market to grow at a CAGR of 9.11% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the biologics manufacturing market. To calculate the market size, the report considers the cost incurred for in-house manufacturing of biologics and the revenue generated by contract manufacturers of biologics across the globe.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
The report, biologics manufacturing market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
Key vendors
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co
- Pfizer
Market drivers
- Introduction of new biologic drugs for treating diseases
- For a full, detailed list, view the full report
Market challenges
- High cost of branded drugs is deterring market growth
- For a full, detailed list, view the full report
Market trends
- Rise in partnerships between traditional biopharma companies and biotechnology startups
- For a full, detailed list, view the full report
Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the Key vendors in this market space?
- What are the market opportunities and threats faced by the Key vendors?
- What are the strengths and weaknesses of the Key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORTPART 03: RESEARCH METHODOLOGYPART 09: CUSTOMER LANDSCAPEPART 11: DECISION FRAMEWORK
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY TECHNOLOGY
PART 08: MARKET SEGMENTATION BY PRODUCT
PART 10: REGIONAL LANDSCAPE
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
PART 16: APPENDIX
List of Exhibits
Executive Summary
New Report Released: - Global Biologics Manufacturing Market 2018-2022The author of the report recognizes the following companies as the key players in the global biologics manufacturing market: Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck & Co, and Pfizer.
Commenting on the report, an analyst from the research team said: “One trend affecting this market is the rise in partnerships between traditional biopharma companies and biotechnology startups. The significant growth of the biologics industry and biotech companies in the past few years has encouraged several major traditional biopharma companies to collaborate with biotechnology startups to develop novel biologics drugs.”
According to the report, one driver influencing this market is the introduction of new biologic drugs for treating diseases. There is a growing demand for biologics for effective treatment of diseases as synthetic drugs have several limitations.
Further, the report states that one challenge affecting this market is the high cost of branded drugs is deterring market growth. A key factor restraining the growth of the global biologics manufacturing market is the high cost of medication.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck & Co
- Pfizer